The vector of anti-MART1 T cell receptor (TCR) is constructed for the engineering of T cell to target Human MART1. The T cells are genetically modified through transduction with a lentiviral vector expressing MART1-specific T cell receptor. And the vector product was designed for the treatment of Melanoma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|TCR-L065||Human anti-MLANA (AAGIGILTV) T Cell Receptor, pMX-IRES-GFP|
|VP-CAR-LC339||Lenti-MART-1(DMF5) CAR (scFv-CD28-41BB-CD3ζ, Melan-A) Viral Particle|
|VP-TCR-C296||Lenti-MART-1 T cell receptor (α24β17) Viral Particle|
|VP-CAR-LC333||Lenti-MART-1(DMF5) CAR (scFv-CD28-CD3ζ, Melan-A) Viral Particle|
|VP-TCR-C284||Lenti-MART-1 (AAGIGILTV) T cell receptor (DMF5) Viral Particle|
|TCR-L067||Murinized (from Human) anti-MLANA (ELAGIGILTV) T Cell Receptor, pMSGV1|
|TCR-C132Z||Human anti-MART1 T cell receptor (DMF4), pCDTCR1|
|TCR-L068||Murinized (from Human) anti-MLANA (ELAGIGILTV) T Cell Receptor[Cysteine-modiﬁed], pMSGV1|
|TCR-L066Z||Murinized anti-MART-1 (ELAGIGILTV) T cell receptor, pCDTCR1|
|VP-CAR-LC331||Lenti-MART-1(DMF5) CAR (scFv-CD3ζ, Melan-A) Viral Particle|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved